Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Deferred Taxes (2016 - 2018)

Apyx Medical filings provide 7 years of Deferred Taxes readings, the most recent being $736000.0 for Q4 2018.

  • On a quarterly basis, Deferred Taxes rose 275.51% to $736000.0 in Q4 2018 year-over-year; TTM through Dec 2019 was $932000.0, a 5.67% increase, with the full-year FY2018 number at $368000.0, up 87.76% from a year prior.
  • Deferred Taxes hit $736000.0 in Q4 2018 for Apyx Medical, up from $196000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $5.9 million in Q4 2014 to a low of -$1.3 million in Q3 2014.
  • Median Deferred Taxes over the past 4 years was $10000.0 (2014), compared with a mean of $605375.0.
  • The widest YoY moves for Deferred Taxes: up 1192.01% in 2014, down 109.74% in 2014.
  • Apyx Medical's Deferred Taxes stood at $5.9 million in 2014, then crashed by 100.85% to -$50000.0 in 2016, then skyrocketed by 492.0% to $196000.0 in 2017, then skyrocketed by 275.51% to $736000.0 in 2018.
  • The last three reported values for Deferred Taxes were $736000.0 (Q4 2018), $196000.0 (Q4 2017), and -$50000.0 (Q4 2016) per Business Quant data.